Delivra Health Brands (TSE:DHB)
:DHB
Want to see TSE:DHB full AI Analyst Report?
DHB Stock Chart & Stats
C$0.14
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.14
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.10 - C$0.37
Previous CloseN/A
Volume20.60K
Average Volume (3M)26.13K
Market Cap
C$3.13M
Enterprise ValueC$3.72M
Total Cash (Recent Filing)C$2.64M
Total Debt (Recent Filing)C$2.33M
Price to Earnings (P/E)―
Beta1.92
Next Earnings
Oct 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding31,261,782
10 Day Avg. Volume58,945
30 Day Avg. Volume26,134
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.30
Price to Sales (P/S)0.41
P/FCF Ratio-7.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)C$12.84M
Bulls Say, Bears Say
Bulls Say
Healthy Gross MarginsA ~45.5% gross margin provides durable product-level profitability typical of branded consumer-health products. If SG&A and distribution are controlled, these margins give the company structural room to invest in R&D, marketing, or channel development and to absorb input-cost swings without immediate margin collapse.
Multi-channel CPG DistributionOperating across CPG and healthcare retail channels diversifies go-to-market risk and supports scale economies in manufacturing and distribution. Long-term channel breadth helps steady demand, facilitates retailer listings, and enables cross-selling and expanded shelf presence versus single-channel suppliers.
Positive Equity BaseA positive equity base (~$2.9M) and moderate leverage (debt/equity ~0.79) provide a financial cushion and access to credit for near-term needs. That balance-sheet headroom supports execution of commercialization or contract-manufacturing initiatives without immediate distress, assuming losses narrow.
Bears Say
Declining RevenueA material TTM revenue decline (-14.1%) signals structural demand or execution issues such as lost distribution, weaker product-market fit, or competitive pressure. Sustained top-line shrinkage erodes scale, increases per-unit costs, and makes investments in growth or profitability harder without a clear recovery plan.
Negative Cash GenerationPersistent negative operating and free cash flow (~-$0.3M TTM) means the business is not self-funding. Over months this forces reliance on external financing, which can dilute shareholders or increase leverage, constraining reinvestment in marketing, product development, or inventory needed to stabilize growth.
Ongoing UnprofitabilityA sustained net margin near -9% indicates the firm has not achieved operating leverage despite decent gross margins. Continued losses shrink equity and reduce strategic flexibility, raising risk that the company cannot fund commercialization or respond to competitive shocks without dilutive or costly capital.
Delivra Health Brands News
DHB FAQ
What was Delivra Health Brands’s price range in the past 12 months?
Delivra Health Brands lowest stock price was C$0.10 and its highest was C$0.37 in the past 12 months.
What is Delivra Health Brands’s market cap?
Delivra Health Brands’s market cap is C$3.13M.
When is Delivra Health Brands’s upcoming earnings report date?
Delivra Health Brands’s upcoming earnings report date is Oct 23, 2026 which is in 133 days.
How were Delivra Health Brands’s earnings last quarter?
Delivra Health Brands released its earnings results on May 29, 2026. The company reported -C$0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.03.
Is Delivra Health Brands overvalued?
According to Wall Street analysts Delivra Health Brands’s price is currently Overvalued.
Does Delivra Health Brands pay dividends?
Delivra Health Brands does not currently pay dividends.
What is Delivra Health Brands’s EPS estimate?
Delivra Health Brands’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Delivra Health Brands have?
Delivra Health Brands has 31,261,782 shares outstanding.
What happened to Delivra Health Brands’s price movement after its last earnings report?
Delivra Health Brands reported an EPS of -C$0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Delivra Health Brands?
Currently, no hedge funds are holding shares in TSE:DHB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Delivra Health Brands
Based in Vancouver, Canada, Delivra Health Brands Inc., through its various subsidiaries, distributes an assortment of lifestyle and wellness goods to a global clientele of consumers and medical patients within regulated jurisdictions. The firm's product line includes cannabis, liquid sleep supplements, powdered sleep aids, edible gummies, and topical pain relief solutions. These items are available under well-known brand labels like LivRelief, Dream Water, and LivRelief Infused. The company was formerly recognized as Harvest One Cannabis Inc.
Technical Analysis
Options Prices
Currently, No data available
---